These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 7998096)
21. General considerations of immunosuppressive therapies--efficacy versus toxicity. Helderman JH Transplant Proc; 2001 May; 33(3A Suppl):2S-3S. PubMed ID: 11376794 [No Abstract] [Full Text] [Related]
22. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Shaw LM; Holt DW; Oellerich M; Meiser B; van Gelder T Ther Drug Monit; 2001 Aug; 23(4):305-15. PubMed ID: 11477311 [No Abstract] [Full Text] [Related]
23. Is EC-MPS effective in reducing GI toxicity of MPA? At what price? Pape L; Ahlenstiel T Pediatr Transplant; 2009 Sep; 13(6):659-60. PubMed ID: 19691563 [No Abstract] [Full Text] [Related]
25. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417 [No Abstract] [Full Text] [Related]
27. Cellcept enhances the rate of apoptosis in T cells after renal transplantation. Kasprzycka M; Wierzbicki P; Nowaczyk M; Górski A; Serafinowicz A; Durlik M; Wyzgał J; Korczak-Kowalska G; Gradowska L; Chmura A Transplant Proc; 1999; 31(1-2):328. PubMed ID: 10083129 [No Abstract] [Full Text] [Related]
28. Monitoring of mycophenolic acid in clinical transplantation. Shaw LM; Pawinski T; Korecka M; Nawrocki A Ther Drug Monit; 2002 Feb; 24(1):68-73. PubMed ID: 11805725 [No Abstract] [Full Text] [Related]
29. Rejection after kidney transplantation: new concepts, new therapeutic options. van der Woude FJ; Hollander AA Transplant Proc; 1998 Aug; 30(5):2419-24. PubMed ID: 9723523 [No Abstract] [Full Text] [Related]